DATA FORM FOR CANCER STAGING - SOFT TISSUE SARCOMA - PEDIATRIC
Form # 785-1-051
| CLIN | PATH | DEFINITIONS | ||
| PRIMARY TUMOR (T) | ||||
| TX | Primary tumor cannot be assessed | |||
| T0 | No evidence of primary tumor | |||
| T1 | Tumor limited to the organ or tissue of origin | |||
| T1a | Tumor 5 cm or less in greatest dimension | |||
| T1b | Tumor more than 5 cm in greatest dimension | |||
| T2 | Tumor invades contiguous organs or tissue(s) and/or with adjacent malignant effusion | |||
| T2a | Tumor 5 cm or less in greatest dimension | |||
| T2b | Tumor more than 5 cm in greatest dimension | |||
| LYMPH NODE (N) | ||||
| NX | Regional lymph nodes cannot be assessed | |||
| N0 | No regional lymph node metastasis | |||
| N1 | Regional lymph node metastasis | |||
| DISTANT METASTASIS (M) | ||||
| MX | Presence of distant metastasis cannot be assessed | |||
| M0 | No distant metastasis | |||
| M1 | Distast metastasis | |||
| PRIMARY TUMOR (pT) | ||||
| pTX | Primary tumor cannot be assessed | |||
| pT0 | No evidence of primary tumor | |||
| pT1 | Tumor limited to organ or tissue of origin; excision complete and margins histologically free | |||
| pT2 | Tumor invades beyond the organ or tissue or origin; excision complete and margins histologically fress | |||
| pT3 | Tumor invades beyond the organ or tissue of origin; excision complete and margins histologically free | |||
| pT3a | Microscopic residual tumor | |||
| pT3b | Macroscopic residual tumor or adjacent malignant effusion | |||
| pT3c | Surgical exploration tumor not resected | |||
| LYMPH NODE (pN) | ||||
| pNX | Regional lymph nodes cannot be assessed | |||
| pN0 | No regional lymph node metastasis | |||
| pN1 | Regional lymph node metastasis | |||
| pN1a | Regional lymph node metastasis completely resected | |||
| pN1b | Regional lymph node metastasis incompletely resected | |||
| DISTANT METASTASIS (pM) | ||||
| pMX | Presence of distant metastasis cannot be assessed | |||
| pM0 | No distant metastasis | |||
| pM1 | Distast metastasis | |||
| CLIN | PATH | CLINICAL STAGE GROUPING (cTNM) | |||
| I | T1a | N0 | M0 | ||
| T1b | N0 | M0 | |||
| II | T2a | N0 | M0 | ||
| T2b | N0 | M0 | |||
| III | Any T | N1 | M0 | ||
| IV | Any T | Any N | M1 | ||
| CLIN | PATH | PATHOLOGICAL STAGE GROUPING (pTNM) | |||
| I | pT1 | pN0 | M0 | ||
| II | pT1 | pN1a | M0 | ||
| pT2 | pN0 | M0 | |||
| pT2 | pN1a | M0 | |||
| IIIA | pT3a | pN0 | M0 | ||
| pT3a | pN1a | M0 | |||
| IIIB | pT3b | Any pN | M0 | ||
| pT3c | Any pN | M0 | |||
| Any pT | pN1b | M0 | |||
| IV | Any pT | Any pN | M1 | ||
THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.
| Comments: |
| Patient Name: |